Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia.
Induction of nitric oxide synthase (NOS2, also designated as iNOS) in the heart is known to occur in response to various stimuli. It is not known, however, whether in vivo hypoxia leads to cardiac NOS2 induction. We thus investigated the effects of normobaric hypoxia (10% O(2)for 8, 15 and 21 days) on NOS2 protein expression and enzyme activity in rat right ventricle (RV) and left ventricle (LV). Chronic hypoxia induced RV hypertrophy: the RV weight to body weight ratio was increased by 45% upon 15 days of exposure, with no change thereafter and no change in left ventricular (LV) weight. Treatment of hypoxic rats with l -NAME for 1 month decreased pulmonary artery pressure and RV hypertrophy compared to hypoxic non-treated rats. NOS2 activity detected by [(3)H]l -arginine to [(3)H]l -citrulline conversion increased in RV during hypoxia, with a maximum at 15 days (+161% of control rats P<0.05), whereas it increased less (by 60%) in LV. In parallel, after 15 days of hypoxia there was a three-fold increase in NOS2 protein abundance detected by Western blotting using an isoform-specific antibody in the RVs (two-fold increase in the LV). Immunochemistry with the specific antibody demonstrated the expression in cardiomyocytes isolated from both ventricles of normoxic and hypoxic rats. Protein kinase C (PKC) content and activity was unchanged in LV of hypoxic rats, but increased in RV as compared with normoxic rats. These results clearly show that, in the heart, NOS2 is upregulated by hypoxia with an expression in cardiomyocytes of both ventricles. In addition, NOS2 is more inducible in the right hypertrophied ventricle than in the left non-hypertrophied hypoxic ventricle.
Rouet-Benzineb
P
P
Unités INSERM U400, Faculté de Médecine, 8 rue du Général Sarrail, Creteil, 94010, France.
Eddahibi
S
S
Raffestin
B
B
Laplace
M
M
Depond
S
S
Adnot
S
S
Crozatier
B
B
D000595:Amino Acid Sequence; D000818:Animals; D015153:Blotting, Western; D002908:Chronic Disease; D004790:Enzyme Induction; D006352:Heart Ventricles; D017380:Hypertrophy, Right Ventricular / Q000201:enzymology / Q000209:etiology / Q000503:physiopathology*; D000860:Hypoxia / Q000201:enzymology / Q000503:physiopathology*; D007150:Immunohistochemistry; D015850:Interleukin-6 / Q000032:analysis; D008297:Male; D008969:Molecular Sequence Data; D009206:Myocardium / Q000201:enzymology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000032:analysis / Q000096:biosynthesis* / Q000737:chemistry; D052247:Nitric Oxide Synthase Type II; D010446:Peptide Fragments / Q000737:chemistry; D011493:Protein Kinase C / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D016277:Ventricular Function, Left; D016278:Ventricular Function, Right
D015850:Interleukin-6; D010446:Peptide Fragments; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D011493:Protein Kinase C; D019331:NG-Nitroarginine Methyl Ester